November 17, 2022 Spike Protein from Vaccine vs. SARS-COV-2 – Chit Chat

November 17, 2022 Spike Protein from Vaccine vs. SARS-COV-2 – Chit Chat

November 17, 2022 Spike Protein from Vaccine vs. SARS-COV-2 – Chit Chat

If you like this content and want more, I am doing a special lifetime membership offer. Click here:

YouTube Special

Want to support this work?:
Buy me a coffee 🙂
Become my patron:
My substack:

#drbeen #koolbeens #COVID

This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

URL list from Thursday, Nov. 17 2022

DrBeen: Medical Education Online


SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies | SpringerLink

SARS-CoV-2 structural features may explain limited neutralizing-antibody responses | npj Vaccines

SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic | Signal Transduction and Targeted Therapy

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen | PNAS

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes – PMC

SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern | PNAS

Frontiers | Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design

Closing coronavirus spike glycoproteins by structure-guided design – PMC

Prefusion Coronavirus Spike Proteins and Their Use | Technology Transfer

Locking Down Shape-Shifting Spike Protein Aids Development of COVID-19 Vaccine – UT News

SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets | eLife

Epitope – Wikipedia